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The number of liver transplants performed yearly has
slowly and steadily increased over the last 10 years,
reaching 6441 procedures in 2005. The number of liv-
ing donor liver transplants performed rose steadily
from 1996 to 2001, when it peaked at 519; since 2003
there have been approximately 320 such procedures
performed each year. The continual increase in the size
of the waiting list for a liver transplant, which peaked
in 2001 at 14 897 patients, was interrupted in 2002 by
the implementation of the allocation system based on
the model for end-stage liver disease and pediatric
end-stage liver disease (MELD/PELD). Activity in all ar-
eas of intestinal transplantation continues to increase.
One-year patient and graft survival following intestine-
alone transplantation now seem to be superior to out-
comes following liver-intestine transplantation. Other
topics covered here include the recent ‘Share 15’ com-
ponent of the MELD allocation system; liver transplan-
tation following donation after cardiac death; simulta-
neous liver-kidney transplantation and waiting list and
post-transplant outcomes for both liver and intestine
transplantation, broken out by a variety of clinical and
demographic factors.
Key words: Allocation policy, MELD/PELD, OPTN,
SRTR, survival rates, waiting list
Introduction
The shortage of organs for transplantation continues to be
a major impediment to providing optimal treatment for pa-
tients with end-stage organ failure. It is particularly acute
in patients requiring extra-renal organs for which dialysis-
equivalent therapies are nonexistent and the prospect of
death while waiting for a transplantable organ is a realistic
possibility.
Liver Waiting List
The continual increase in the size of the waiting list for a
liver transplant, which peaked in 2001 at 14 897 patients,
was interrupted in 2002 by the implementation of the allo-
cation system based on the model for end-stage liver dis-
ease and pediatric end-stage liver disease (MELD/PELD).
The important drop registered between 2001 and 2003 in
the number of candidates actively waiting for a liver trans-
plant (15%) was followed by a slow increase over the last
2 years (12 822 candidates in 2005, compared to 12 650 in
2003); the exact significance of this upward trend is unclear
(Figure 1). Conversely, the percentage of listed patients on
the inactive waiting list has remained relatively constant at
approximately 25%, with the majority of patients (78%) on
the inactive list in 2005 being listed for two or more years.
Demographic factors
Age: The age distribution among patients active on the
waiting list underwent significant changes over the last 10
years. While in 1996 most candidates were equally dis-
tributed between the 18–49 and 50+ age categories, the
group aged 50–64 alone now makes up nearly 60% of the
patients active on the waiting list (Figure 2). This shift most
likely reflects the changing demographics of U.S. society,
which has an increasingly older population. In contrast,
the number of patients 18–49 years old remained approx-
imately the same over the decade, but this age range’s
percentage of all active waiting list patients declined from
47% in 1996 to 27% in 2005. A similar trend is seen among
pediatric (<18) candidates, who continue to represent less
than 5% of the waiting list, while older adults (65+) reached
11% of the waiting list for the first time in 2005.
Race and ethnicity: White candidates continue to make
up most of the liver waiting list, but their percentage has
slowly declined (from 77% in 1996 to 72% in 2005), cur-
rently reaching a level close to the one observed in the
general population. The death rate for whites on the wait-
ing list is 123 deaths/1000 patient-years (PY) at risk, very
close to the death rate for the overall waiting list. The num-
bers of African American and Asian patients on the waiting
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Source: 2006 OPTN/SRTR Annual Report, Table 9.1a.
Figure 1: Number of patients on the liver waiting list, active
at year-end, 1996–2005.
list have remained relatively constant (approximately 7%
and 5% of the waiting list, respectively). While other races
have increased their number of active candidates by 90–
131%, the number of Hispanics active on the waiting list
has nearly tripled in the last 10 years. Asian candidates con-
tinue to have the lowest mortality rate among all races (87
deaths/1000 PY at risk), while the African Americans have
the highest rate (154 deaths/1000 PY at risk).
Gender: The number of females active on the waiting list
continues to be lower than the number of males, and even
higher numbers of male registrations have widened this
gap further. In 2004 and 2005, women made up approx-
imately 40% of the active list, down from 44% in 1996.
The death rate on the waiting list continues to be lower for
females (119 deaths/1000 PY at risk) than for males (130
deaths/1000 PY at risk).
Medical factors
Diagnosis: The distribution of diagnoses at listing has
been very stable since 2000. Noncholestatic liver disease
remains the largest single diagnostic category, represent-
Source: 2006 OPTN/SRTR Annual Report, Table 9.1a.
Figure 2: Age distribution of patients on the liver waiting list,
active at year-end, 1996–2005.
ing about 72% of the waiting list. Although the percent-
age of patients with noncholestatic liver disease has in-
creased slightly (72% in 2005 vs. 67% in 1996) the abso-
lute number of patients with this diagnosis more than dou-
bled over the decade. Biliary atresia has consistently been
associated with the lowest mortality risk (52 deaths/1000
PY in 2005), while patients diagnosed with acute hepatic
necrosis (165 deaths/1000 PY at risk), malignant neoplasm
(132 deaths/1000 PY at risk) or metabolic diseases (123
deaths/1000 PY at risk) remain the diagnoses with the high-
est death rates.
Previous transplant: The proportion of candidates await-
ing liver transplantation who underwent a previous trans-
plant of any kind steadily decreased between 1996 and
2004 (Figure 3). However, in 2005 the percentage of re-
transplant candidates on the active liver transplant waiting
list increased for the first time in the decade—even though
the increase was minor (3.3% in 2005, compared to 3.1%
in 2004). The percentage of patients listed for a second liver
transplant decreased from 5% in 1996 to 3% in 2005, pri-
marily because the total number of wait-listed patients rose
over the same period (6280 at year-end 1996 vs. 12 822 at
year-end 2005).
Waiting list death rates
Very young candidates (<1 year) have the highest mortality
on the waiting list (722 deaths/1000 PY at risk), followed
by pediatric candidates aged 1–5 years (186 deaths/1000
PY at risk). Among candidates six and older at listing, the
death rates increased with age, with the 6- to 10-year-olds
having the lowest mortality rate (39 deaths/1000 PY at risk)
and the group older than 65 years having the highest (158
deaths/1000 PY at risk).
Liver allocation system
The current allocation system gives priority to candidates
listed as Status 1A or 1B, followed by non-Status 1
Source: 2006 OPTN/SRTR Annual Report, Table 9.1a.
Figure 3: Percentage of candidates on the liver waiting list
with a previous transplant by year, 1996–2005.
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candidates in decreasing order of MELD/PELD score. Ad-
ditionally, exceptions to the usual listing order are granted
for patients with hepatocellular carcinoma (HCC). Initially,
T1 (one tumor ≤ 1.9 cm) and T2 (one nodule 2.0–5.0 cm;
two or three nodules all <3.0 cm) tumors were eligible for
exception. Concerns that T1 lesions were difficult to di-
agnose accurately—and that HCC patients were perhaps
being given excessive priority—led to a policy change in
2004 allowing exception for only those patients with T2
tumors.
Since August 2005, following a change in policy for Status
1 listing, adult and pediatric candidates must have fulmi-
nant hepatic failure, primary nonfunction of a transplanted
liver, hepatic artery thrombosis or acute decompensated
Wilson’s disease to be listed as Status 1A. Status 1B is ex-
clusively for pediatric patients with acute decompensation
of chronic liver disease. The total number of candidates
listed as Status 1 (A or B) did not change appreciably in
2005 compared to previous years (17 patients at year-end),
representing only 0.1% of the total number of active pa-
tients on the waiting list in a snapshot at year-end. The
apparently low percentage is explained by the fast rate of
events among such candidates: 54% of the patients listed
with Status 1 in 2004 and 2005 were transplanted within
15 days of listing, an additional 12% recovered and 16%
died or were considered too sick to be transplanted. Only
9% of patients were still waiting for a transplant 15 days
after being designated Status 1. Most of the transplants,
recoveries and deaths occurred during the first 7 days after
listing. The risk of death on the waiting list while a Status
1 candidate was 6619 deaths/1000 PY at risk, more than
50 times higher than the average risk for the waiting list
overall.
The rest of the waiting list consisted of candidates listed
at their calculated MELD/PELD score. Based on end-of-
year snapshots of the waiting list, the distribution of MELD
scores among adult candidates has been remarkably sta-
ble since the MELD system was implemented (Figure 4).
Between 42% and 46% of the candidates had a MELD
score less than 11, while 47–51% of the candidates had a
MELD score between 11 and 20. At the end of each year
from 2002 to 2005, 4% of adult candidates were listed at a
MELD score greater than 20. A different trend can be ob-
served among pediatric candidates, where, before 2005,
the overwhelming majority (80–82%) had a PELD score of
10 or less, while only 14–17% had a PELD score of 11–
20. In 2005 the distribution shifted toward higher PELD
scores (66% of the pediatric candidates listed at PELD
<11, 26% at PELD 11–20, 8% listed at PELD >20). As ex-
pected, the unadjusted risk of death was higher for those
with higher MELD/PELD scores. For adults, there were
34 deaths/1000 PY at MELD 6–10, 97 deaths/1000 PY at
MELD 11–20, 643 deaths/1000 PY at MELD 21–30, and
4220 deaths/1000 PY at MELD >30. Candidates for a liver
transplant with a hepatocellular carcinoma T1 (HCC T1) ex-
ception faced an unadjusted risk of dying of 90/1000 PY at
∗Source: 2006 OPTN/SRTR Annual Report, Table 9.1a.
Figure 4: Distribution of MELD/PELD status among patients
on the liver waiting list, at year-end, 2002–2005.
risk, while those candidates with an HCC T2 exception had
a risk of 149 deaths/1000 PY at risk.
A recent analysis of Scientific Registry of Transplant Re-
cipients (SRTR) data examined geographic differences in
MELD score, risk of death on the waiting list and transplant
rates (1). Roberts et al. found that the average MELD and
risk of death varied somewhat by region, but that transplant
rates varied much more by region, with 7 of the nation’s 11
regions having transplant rates significantly different from
the national average. For more discussion of regional dif-
ferences in MELD score, see the section on ‘Share 15’,
below, and the paper by Roberts et al.
Deceased Donor Liver Recipients
The total number of transplants performed yearly has in-
creased slowly and fairly steadily over the last 10 years,
reaching 6441 procedures in 2005. This rise is mainly at-
tributable to deceased donor liver transplantation (DDLT),
the number of which increased by 30% since 2001 after
rising more slowly for the previous decade.
Demographic factors
Distribution of demographic factors among deceased
donor transplant recipients follows the waiting list distri-
bution closely.
Age: The number of pediatric recipients of DDLT in-
creased modestly from 472 in 1996 to 509 in 2005, but
the percentage of deceased donor pediatric transplants de-
creased from 12% to 8% over the same period. This shift
mirrors the trend in waiting list registrations. The number
of adult patients aged 18–49 receiving a DDLT remained
relatively stable over the decade, but the percentage of
total DDLT decreased considerably, dropping from 44% in
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1996 to 29% in 2005. In contrast, the number of adults
50 and older who were transplanted more than doubled
over the same period; this group now accounts for 62% of
all DDLT performed. In 1996, 276 over 65 recipients were
transplanted; by 2005, the number had increased to 604.
Gender, race, ethnicity, blood type: The number of
males receiving a DDLT steadily increased over the past
decade, rising from 58% in 1996 to 67% in 2005. This
change is likely due to the increased prevalence of hep-
atitis C as the etiology of end-stage liver disease and the
preponderance of males with this diagnosis. The percent-
age of whites who received DDLT decreased from 76% in
1996 to 72% in 2005. Over the last 10 years, African Amer-
icans represented a steady 9–10% of all the recipients of
a DDLT. The distribution of blood groups among recipients
of DDLT has remained constant and reflects the distribu-
tion of blood types in the general population. Of deceased
donor recipients transplanted in 2005, approximately 45%
were type O, 38% were type A, 12% were type B and 5%
were type AB.
Insurance: More than half of the recipients of a liver trans-
plant have private insurance as their main source of pay-
ment. A decade ago, there were more than twice as many
recipients with a private insurance than recipients with pub-
lic insurance, for both deceased donor and living donor liver
transplants (LDLT). In 2005, the percentage of DDLT recip-
ients with private insurance as their main source of pay-
ment decreased to 58%, while the percentage of LDLT
increased to 74%.
Medical factors
This year’s report does not examine trends in immunosup-
pressive therapy for liver transplantation. For an extensive
examination of this topic, see Meier-Kriesche et al. in the
2005 SRTR Report on the State of Transplantation (2).
Previous transplant: There has been a slight decline in
the percent of DDLT recipients who had a prior transplant
of any kind. In 1996, 12% had received a previous trans-
plant; in 2005, this percentage decreased to 10%. For an
extended discussion of liver retransplantation, see ‘Repeat
Organ Transplantation in the United States, 1996–2005’, an
accompanying article in this report (3).
Partial liver grafts: The number of transplants using a
partial or split liver increased by almost 40% over the
last 10 years (228 in 2005, compared to 165 in 1996)
(Figure 5). However, partial and split-liver transplants now
represent less than 4% of the total number of liver trans-
plants.
Diagnosis: DDLT patients with noncholestatic cirrhosis as
the primary indication for transplant represented approxi-
mately 62% of DDLT recipients, a percentage similar to that
seen for the last decade. The rest of the recipients were
As percentage of the total number of liver transplants
Source: 2006 OPTN/SRTR Annual Report, Table 9.4a.
Figure 5: Number and percentage of split/partial transplant
recipients by year, 1996–2005.
listed with a diagnosis of cholestatic liver disease (7%,
continually decreasing over the last 10 years), malignant
neoplasm (8%, which experienced a significant increase in
2002, following the implementation of the exception score
system that gives additional MELD points to candidates
listed with HCC), acute hepatic necrosis (8%), biliary atre-
sia (3%), metabolic diseases (3%) or other diagnosis (8%).
The number of patients transplanted for HCC has shown
a steady increase since the implementation of the MELD
system that grants exception points for this indication. In
2001, 3% of DDLT were for HCC. In 2003, following the
implementation of the MELD system, this number rose
to 6%; it has risen each subsequent year. The proportion
of patients transplanted as Status 1 has slowly decreased
since the implementation of the MELD system in 2002. In
2005, 9% of DDLT recipients and 7% of LDLT recipients
were Status 1 at the time of transplant.
Posttransplant death rates
For DDLT, recipient death rates during the first year follow-
ing transplantation declined, reaching the lowest value in
the last decade in 2004 (Figure 6). In 2004, older adults
Source: 2006 OPTN/SRTR Annual Report, Table 9.7a.
Figure 6: Death rates at 1 year following transplantation by
year, 1996–2004.
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Source: 2006 OPTN/SRTR Annual Report, Table 9.7a.
Figure 7: Death rates at 1 year following transplantation by
severity of disease, 2004.
(65+ years) experienced the highest death rates (226
deaths/1000 PY at risk), while adolescents (11–17 years)
had the lowest death rates (60 deaths/1000 PY at risk)
among all recipients of a DDLT. Asians continue to have the
lowest posttransplant death rates among all racial groups
(in 2004, 136 deaths/1000 PY at risk). Males experienced a
higher mortality rate than females in the first year following
DDLT (149 vs. 160 deaths per 1000 PY).
Posttransplant death rates among recipients transplanted
at Status 1 dropped continuously over the last 10 years.
Adults transplanted at low MELD continued to experience
higher 1-year death rates than those transplanted at inter-
mediate MELD scores (Figure 7).
Evaluation of an Allocation Policy Change
to Share Livers Regionally to Candidates
with Meld Scores Greater Than 15
Since 2002, deceased donor liver allocation in the United
States has been based on the risk of candidate death in
the absence of a transplant (medical urgency) using MELD.
Due to limitations of the size of the initial sharing area (lo-
cal donation service area, or DSA), many livers were trans-
Table 1: Comparison of allocation rules for deceased donor livers
February 2002 to January 2005 January 2005 to present
Local—Status 1 Local—Status 1
Regional—Status 1 Regional—Status 1
Local—MELD/PELD Local–MELD/PELD ≥ 15
Regional—MELD/PELD Regional—MELD/PELD ≥ 15
Local—MELD/PELD < 15
Regional—MELD/PELD < 15
National—Status 1 National—Status 1
National—MELD/PELD National—MELD/PELD
Source: OPTN. Boldface indicates the updated Share 15 system,
which went into effect January 12, 2005; the other rules were
unchanged.
planted locally into recipients with low MELD scores when
candidates with higher MELD scores were waiting in ad-
joining DSAs within the same region. Previous analyses
have shown that recipients transplanted at MELD <15 do
not have a significant survival benefit from transplantation
(4). In response to these observations, a change in national
liver allocation policy was approved and became effective
in January 2005 (5). The allocation primacy of local and re-
gional Status 1 candidates was unchanged. Under the new
policy, after Status 1 candidates, offers of livers are to be
made to candidates with MELD ≥15 outside the procuring
DSA (but within the same region) if there are no local can-
didates with MELD scores ≥15. Donor livers are allocated
to local candidates with MELD <15 only if there are no
regional candidates with MELD ≥15 (Table 1).
To examine the early effects of this policy change, the
SRTR analyzed liver transplant data from before and after
the sharing policy (‘Share 15’). The analysis was presented
in a preliminary form at the International Liver Transplanta-
tion Society meeting in Milan in 2006 (6). The pre-Share 15
era included 5301 DDLT from January 12, 2004, to January
11, 2005; the post-Share 15 era included 5541 transplants
from January 12, 2005, to January 11, 2006.
The proportions of candidates with MELD ≥15 at the time
of listing in the two periods were very similar (75.8%
vs. 76.3%, respectively). The distribution of reasons for
removal from the liver waiting list showed a modest
shift toward a higher proportion removed for deceased
donor transplant and a lower proportion removed for death
(Figure 8).
There was a 36% drop in the proportion of liver trans-
plant recipients with MELD score <15 (n = 627; 11.8%
vs. n = 423; 7.6% for pre-Share 15 vs. post-Share 15, re-
spectively). The proportion of transplants to recipients with
MELD ≥15 increased in every region and in most DSAs
(Figures 9 and 10). DSAs with lower percentages of recip-
ients with MELD ≥15 before the policy change had the
Source: SRTR Analysis, May 2006.
Figure 8: Distribution of reasons for removal from the liver
waiting list.
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Source: SRTR Analysis, May 2006.
Figure 9: Percentage of transplant recipients with
MELD/PELD 3 15 by OPTN region.
largest increases after the policy was changed, reducing
variability in MELD at transplant across the country. The
number of DSAs where at least 90% of the liver trans-
plants were in recipients with MELD ≥15 increased from
27 to 42 (55–86%; p = 0.017) (Figure 11).
Most interestingly, despite major changes in the MELD
scores of recipients and marked reductions in the num-
ber of low-MELD transplants being performed after the
implementation of the new policy, there was almost no
change in the number of livers shared outside the local DSA
under the new system. Specifically, there was no change
in the proportion of locally transplanted or regionally trans-
planted livers. This suggests that the policy goals were
realized through behavioral changes at the local level. De-
cisions at the local DSA level to accept donor livers for
high-MELD candidates that would have previously been
reserved for lower-MELD candidates (by turning down
such offers for the higher-MELD candidates) may explain
this phenomenon, though this has not been examined.
Methodologies to examine organ and offer acceptance are
now being developed that will allow for further dissection
of this process. In the meantime, the policy appears to
have had its intended effect.
Source: SRTR Analysis, May 2006.
Figure 10: Percentage of transplant recipients with
MELD/PELD ≥ 15, by DSAs performing liver transplants.
Source: SRTR Analysis, May 2006.
Figure 11: Number of DSAs with at least 90% of transplants
at MELD/PELD ≥ 15.
Living Donor Liver Transplantation
The overall incidence of LDLT increased each year between
1996 and 2001, peaking at 10% of the total number of
liver transplants performed (Figure 12). Since then, the per-
centages have decreased to 5% of the total. Nationally,
this decline may reflect the well-publicized deaths of two
U.S. donors as well as the introduction of the MELD/PELD
system and the increased use of so-called expanded cri-
teria liver donors. However, the incidence of LDLT varies
greatly throughout the country. In regions where the aver-
age MELD score for DDLT is 25 or greater (Regions 1, 5,
7 and 9), the percentage of patients undergoing LDLT con-
tinues to increase and currently represents approximately
10% of all liver transplants. Between 2001 and 2005, the
percentage of LDLTs in regions 1, 5, 7 and 9 ranged from
9% to 13%. These above-average percentages may re-
flect relatively low regional numbers of deceased donors
and a consequent difficulty in obtaining deceased donor
∗LDLT as percentage of the total number of liver transplants
Source: 2006 OPTN/SRTR Annual Report, Tables 9.4a and 9.4b.
Figure 12: Number of liver recipients by type of transplant
and year, 1996–2005.
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∗LDLT as percentage of the total number of liver transplants
Source: SRTR Analysis, May 2006.
Figure 13: Average MELD at deceased donor liver transplant
and percentage of LDLT, by OPTN region.
livers for patients in a timely manner. For example, Region
1 had a total of 584 deceased donors for this period and
an average MELD at time of transplant of 26.7. The only
other region to have less than 1000 deceased donors in
this period was Region 6—which performed a total of 637
transplants, all from deceased donors, but with an average
MELD of 21.7 (Figure 13). Another possible explanation
for the regional variance in LDLT is regional difference in
expertise and preference.
The majority of living liver donors are genetically related
to their recipients. However, the nature of the relation-
ship has changed over time (Figure 14). In 1996, 87% of
living donors were parents donating to their children; in
2005, this percentage had decreased to 16%. Conversely,
in 2005, child-to-parent (27%) and sibling-to-sibling (15%)
donations made up the largest groups of living donors, fol-
lowed by other related donors (10%). The percentage of
spousal and other genetically unrelated donors has also
increased, rising from 3% in 1996 to 18% in 2005.
Source: 2006 OPTN/SRTR Annual Report, Table 9.4b.
Figure 14: Relation of donor to recipient for LDLT by year,
1996–2005.
Source: 2006 OPTN/SRTR Annual Report, Table 9.1a.
Figure 15: Distribution of age among living donor transplants
by year, 1996–2005.
Living donor recipients
The number of LDLT performed annually rose steadily from
1996 to 2001, when it peaked at 519. The number of LDLT
dropped sharply afterward; since 2003 there have been
approximately 320 such procedures performed each year.
Two reasons commonly cited for this drop since 2001 are
the much-publicized deaths of two living liver donors and
the introduction of the MELD allocation system around that
same time (7,8).
Age: Since 1996, when 95% of the living donor trans-
plants were performed on patients younger than 18 years
old, the age distribution of LDLT recipients has shifted con-
tinuously toward older recipients. In 2005, only 18% of
LDLT recipients were pediatric candidates, 51% were 50
or older, and 8% were 65 or older (Figure 15).
Gender, race, ethnicity, blood type: The majority of
LDLT recipients continue to be white. The percentage has
risen slowly from 73% in 1995 to 77% in 2005. There has
been a steady decrease in the percentage LDLT recipients
who are African American (4% in 2005, down from 13%
in 1996 and 18% in 1998). The percentage of LDLT recipi-
ents who are Hispanic/Latino has dropped too, though not
as much (10% in 2005, down from 13% in 1996 and 19%
in 1999). Since 2000, most LDLT recipients have been male
(58% in 2005). The distribution of blood types is similar to
that seen among recipients of DDLT and among the gen-
eral population.
Diagnosis: The primary diagnosis of LDLT recipients has
undergone considerable change. In 1996, most of cases
were performed for biliary atresia (61%), followed by acute
hepatic necrosis (18%), with noncholestatic liver disease
representing 6% and malignancies 5%. In 2005, only 7%
were performed for biliary atresia. This shift most likely
represents the implementation of the MELD/PELD sys-
tem, which has increased the pediatric population’s access
1382 American Journal of Transplantation 2007; 7 (Part 2): 1376–1389
Liver and Intestine Transplantation, 1996–2005
Includes all liver transplants from 1/1/96 through 12/31/05.
Source: SRTR Analysis, November 2006.
Figure 16: Unadjusted patient and graft survival of liver re-
cipients, by deceased and living donor.
to available deceased donor livers. In contrast, LDLT for
noncholestatic disease increased to 46% in 2005, a trend
similar to that seen in recipients of deceased donor liv-
ers. Of note, 21% of LDLT recipients were transplanted for
cholestatic disease in 2005, compared to only 7% for DDLT
recipients.
Liver transplant patient survival
Among the most recent transplant cohorts for whom
follow-up data are available, patient survival following DDLT
was 93% at 3 months, 87% at 1 year, 79% at 3 years
and 73% at 5 years. These survival rates are adjusted for
recipient age, gender, race and diagnosis at the time of
transplant. The corresponding patient survival was slightly
better for recipients of LDLT (96%, 92%, 83% and 77%,
respectively). A very similar pattern can be noted when
analyzing graft survival.
Figure 16 shows unadjusted patient and graft survival for
all LDLT and DDLT recipients between 1996 and 2005. Al-
Source: 2006 OPTN/SRTR Annual Report, Table 9.12b.
Figure 17: Adjusted patient survival of living donor liver re-
cipients at various time intervals, by age group.
Source: 2006 OPTN/SRTR Annual Report, Table 9.12a.
Figure 18: Adjusted patient survival of deceased donor liver
recipients at various time intervals, by age group.
though these statistics may suggest that results for LDLT
are superior to those for DDLT, it is important to keep in
mind that, in general, LDLT recipients have a lower acu-
ity of illness (e.g. lower MELD score), and would thus be
expected, other things being equal, to have better post-
transplant outcomes. In addition, these 10-year cohorts
subsume most or all of the learning curve effect that has
been previously described for centers performing LDLT (9),
so new centers embarking on LDLT programs might not
necessarily have as good outcomes as shown here.
Demographic factors: Adjusted patient survival tended
to decline with recipient age in adults who received LDLT,
with the gap being more evident as the posttransplant
time increases (Figure 17). The same pattern holds for
long-term survival of DDLT recipients, while no age-related
pattern is apparent in short-term survival (Figure 18). After
1 year, African Americans displayed lower survival rates
Source: 2006 OPTN/SRTR Annual Report, Table 9.12a
Figure 19: Adjusted patient survival of deceased donor liver
recipients at various time intervals, by diagnosis.
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Source: 2006 OPTN/SRTR Annual Report, Table 9.12b
Figure 20: Adjusted patient survival of living donor liver re-
cipients at various time intervals, by diagnosis.
(84% at 1 year, 74% at 3 years, 65% at 5 years for DDLT
recipients) than other racial groups (e.g. 87%, 79% and
74%, respectively, for whites).
Medical factors: Adjusted patient survival at 3 months
among DDLT recipients was similar regardless of the eti-
ology of liver disease (between 90% and 94%). Patients
whose main indication for transplant was biliary atresia ex-
hibited the highest survival rates beyond 3 months (91%
at 1 year, 86% at 3 years, 85% at 5 years), followed by
recipients with cholestatic liver disease and those with
metabolic disease. Diagnoses of malignant neoplasm or
acute hepatic necrosis were associated with reduced long-
term survival probability (75% at 3 years and 64% at
5 years for malignant neoplasm, respectively; 74% and
70% for acute hepatic necrosis), compared to other di-
agnoses (Figure 19). Survival rates for LDLT recipients
showed some similar patterns (e.g. relatively high for bil-
iary atresia and low for malignant neoplasm, 5 years af-
ter transplant), but were considerably lower for recipi-
Source: 2006 OPTN/SRTR Annual Report, Table 9.14a
Figure 21: Unadjusted patient survival of deceased donor
liver recipients at various time intervals, by severity of dis-
ease.
∗As percentage of all DDLT.
Source: SRTR Analysis, May 2006.
Figure 22: Number and percentage of DCD liver transplants,
by year, 1996–2005.
ents with metabolic disorder at every follow-up time point
(Figure 20).
Unadjusted patient survival at 3 months was lower for pa-
tients who received a DDLT at Status 1 (87%) or at MELD
>30 (89%) than for patients who received a transplant
at low or intermediate MELD scores (Figure 21). Further
out from the time of transplant, the discrepancy between
Status 1 recipients and MELD 11–20 recipients decreased
(84% vs. 89%, respectively, at 1 year; 80% vs. 81% at 3
years) and recipients who were at MELD >30 at time of
transplant fared worse (72% at 3 years). It is interesting to
note that DDLT recipients with MELD scores 6–10 at trans-
plant had good short-term survival, while their survival at 3
years was only slightly better than that of recipients with
high MELD (76% at 3 years).
Donation After Cardiac Death Liver
Transplants
There were 826 DCD liver transplants among the 48 593
DDLT performed between 1996 and 2005. While the over-
all proportion of DCD liver transplants was 1.7% of all DDLT
over the decade, the annual number of DCD liver trans-
plants increased from 0.3% in 1996 (n = 12) to 4.3% in
2005 (n = 264) (Figure 22). The proportion of DCD donors
from whom a liver was recovered increased from 38% in
1996 to 70% in 2005, suggesting dissemination of this ap-
proach to liver donation throughout the transplant commu-
nity. The number of transplant programs performing DCD
liver transplants increased from 7 in 1996 to 33 in 2005
(Table 2).
Graft and patient outcomes following DCD liver transplan-
tation have been reported to be inferior to those using do-
nation after brain death (DBD) donors (8,10–12). However,
there is some preliminary evidence that changes in prac-
tice are leading to improved results for DCD liver trans-
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Table 2: Number of centers that performed at least one DCD
liver transplant, by year (1996–2005)











Source: SRTR Analysis, May 2006.
plants. In 2003, 1-year patient survival rates after DCD and
DBD liver transplants were 76% and 85%, respectively,
but they were nearly identical (86.1% vs. 85.9%) in 2004
(Figure 23). Some of the improvement in patient sur-
vival might be attributable to more prompt or effective re-
transplantation after DCD liver graft failure, but graft sur-
vival data appear to parallel the patient survival results
(Figure 24).
While these early trends cannot be rigorously assessed, it
suggests that the adverse effect of a DCD liver transplant
on early outcome may be abating. At a recent consensus
conference on donation after cardiac death (DCD), it was
averred that limiting warm ischemia time in the donor be-
tween withdrawal of support and declaration of death to
30 min (vs. the 60-min limit generally used for DCD kid-
ney recovery) might have a beneficial effect on DCD liver
function (13). Mean warm ischemia time has decreased
slightly (from 19 to 16 min) over the past few years; more
important, the proportion of DCD livers recovered after
more than 30 min has dropped from 16% to 10%.
The effect of warm ischemia time on outcome is clearly
seen in a multivariable Cox regression model of time to
graft failure after DCD liver transplant. After adjustments
for recipient factors and year of transplant, each 5-min pe-
Source: SRTR Analysis, May 2006.
Figure 23: Patient survival of DCD donors and DBD donors at
1 year following liver transplantation, 2003–2004.
Source: SRTR Analysis, May 2006.
Figure 24: Graft survival of DCD donors and DBD donors at 1
year following liver transplantation, 2003–2004.
riod of warm ischemia time was associated with a 16%
higher risk of graft failure (hazard ratio 1.157; 95% confi-
dence interval 1.070–1.250; p = 0.0002).
It has been suggested that long-term outcomes after DCD
liver transplantation will be adversely affected by the devel-
opment of ischemic-type biliary strictures (10). Continued
observation of recipients of DCD liver transplants is thus
warranted to determine whether recent improvements in
short-term outcome will be sustained over time.
Simultaneous Liver-Kidney Transplantation
An increase in simultaneous liver-kidney (SLK) transplan-
tation coincided with the introduction of MELD prioritiza-
tion for liver transplant. Hepatorenal syndrome has become
an increasingly important indication for liver transplanta-
tion, and liver transplant candidates with intrinsic renal dis-
ease are receiving transplants at increased rates. In fact,
a liver transplant candidate on dialysis starts with a MELD
Source: Draft 2006 OPTN/SRTR Annual Report, Tables 1.7 and
1.8.
Figure 25: Recipients of liver and SLK transplants by year,
1996–2005.
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Figure 26: Distribution of candidates listed for intestine ver-
sus liver-intestine transplant, by age group and year, 1991–
2005.
score of 20 even before INR and serum bilirubin levels are
added to the MELD score calculation. As serum creatinine
is heavily weighted in the equation used to calculate MELD
scores, renal dysfunction has become increasingly present
in liver transplant recipients.
In the first year of the MELD allocation system, the number
of SLK transplants rose by more than 50% (134 in 2001,
210 in 2002). As shown in Figure 25, since the introduction
of MELD allocation, the percentage of liver transplants per-
formed as SLK transplants has continued to increase (5.3%
in 2005 vs. 2.6% in 2001). Nearly 10% of liver recipients
were on dialysis at the time of transplant, received an SLK
transplant, or both (SRTR analysis; data not shown).
It is important to note that in the OPTN allocation rules,
listing for a solitary kidney transplant requires a calculated
glomerular filtration rate (GFR) of less than 20 mL/min, yet
there is no GFR listing threshold for SLK (14). This differ-
ence in criteria has led to a difference in the degree of
renal impairment at transplant between SLK and solitary
kidney recipients. In fact, only about 60% of those receiv-
ing SLK are on dialysis at transplantation (SRTR analysis;
Source: SRTR Analysis, May 2006.
Figure 27: Age distribution of candidates listed for intestine
versus liver-intestine transplant, by year, 1991–2005.
∗Death rates for 2006 are based on a very low reported number
of deaths and therefore are highly unstable
Source: SRTR Analysis, May 2006.
Figure 28: Death rates of candidates listed for an intestine or
liver-intestine transplant, by year, 2000–2006.
data not shown). These facts are disturbing to those pri-
marily involved with kidney transplantation. With the heavy
weighting of serum creatinine in the MELD score, and the
subsequent increased priority of those with significant re-
nal dysfunction and increased number of SLK transplants, a
call has been made for consistent evaluation and selection
criteria for SLK transplants in those liver transplant candi-
dates with renal insufficiency.
Intestine Transplantation
Intestines are the least transplanted abdominal organ, but
the rate of intestine transplantation is increasing the most.
Although significant problems persist, intestine transplant
outcomes have steadily improved, as detailed below.
Because of the small number of such transplants, we
have grouped together sequential 5-year eras of trans-
plants when discussing trends: 1991–1995, 1996–2000
and 2001–2005.
∗Death rates for 2006 are based on a very low reported number
of deaths and therefore are highly unstable
Source: 2006 OPTN/SRTR Annual Report, Table 10.3.
Figure 29: Death rates on the waiting list for candidates listed
for an intestine transplant, by age group and year, 2000–2006.
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Table 3: Death rates for candidates listed for an intestine trans-
plant, by liver listing and age group
Age group and Number of Annual death rates per
listing combination deaths 1000 patient-years at risk
Pediatrics—intestine only 13 62.2
Pediatrics—liver/intestine 201 351.5
Adults—intestine only 18 153.2
Adults—liver/intestine 56 475.8
Source: SRTR Analysis, May 2006.
Intestine waiting list
Intestine transplant listings have increased significantly.
The number of listings has increased from 236 (1991–
1995) to 1161 (2001–2005). Since previous results have
indicated that most intestinal transplants have been per-
formed together with a liver transplant, we have separated
all candidates listed for intestinal transplants into two sub-
sets: all candidates listed for both a liver and an intestine,
and candidates listed only for an intestine and never for
a liver. In the three sequential eras, liver-intestine candi-
dates have made up 87%, 80% and 70% of the waiting
list population, respectively, indicating that while most in-
testine listings were combined with a liver listing in all eras,
this practice has been decreasing (Figure 26). Alternatively,
when the intestinal waiting list population was divided by
age, pediatric candidates made up 79%, 74% and 66%,
respectively (Figure 27). While pediatric patients are listed
for intestine transplants more often than adults, this gap is
progressively narrowing.
Waiting list mortality has been consistently higher with can-
didates waiting for intestine transplants than for candidates
waiting for any other organ transplant, primarily reflect-
ing the outcomes of the liver-intestine candidate subset
(Figure 28). Although there has been significant annual vari-
ability, in general waiting list mortality appears to be stable
among pediatric candidates and increasing in adults (Fig-
ure 29). When waiting list mortality rates since 2000 were
compared, there was a 5.7-fold higher mortality among pe-
diatric liver-intestine candidates compared to the intestine-
Source: SRTR Analysis, May 2006.
Figure 30: Percentage of intestines procured and trans-
planted, by OPTN region, 2001–2005.
Source: SRTR Analysis, May 2006.
Figure 31: Number of intestine and liver-intestine transplants
performed, by age group and year, 1991–2005.
only candidates. Adult liver-intestine-candidates had a 3.1-
fold higher mortality than adult intestine-only candidates
(Table 3).
Intestine waiting list mortality was higher for adults than
for pediatric candidates. Among intestine-only candidates,
adults had a 2.5-fold higher mortality rate than pediatric can-
didates. Similarly, among liver-intestine candidates, adults
had a mortality rate 1.4-fold higher than that of pediatric
candidates.
Intestine procurement
Intestine procurements have increased since 2000 al-
though the percentage of multi-organ donors from whom
an intestine was procured remains low (2%). To put this
into perspective, 0.22% of patients on the waiting list at
the end of 2005 were waiting for an intestine graft, while
0.64% of transplants performed in 2005 involved an in-
testine transplant. There is significant variability between
regions regarding the percentage of donors from whom an
Source: SRTR Analysis, May 2006.
Figure 32: Distribution of intestine and liver-intestine trans-
plants, by age group and year, 1991–2005.
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Figure 33: Adjusted patient survival following intestine trans-
plantation, 1991–2005.
intestine was procured, from 3.0% (Region 3) to 0.9% (Re-
gion 9) in 2001–2005 (Figure 30). Over the same period, the
most intestinal transplants (234) were performed in Region
2 and the fewest (none) were performed in Region 6.
Intestine transplantation
The number of intestine transplants performed has
been steadily increasing: total transplant numbers have
increased from 115 (1991–1995) to 425 (2001–2005)
(Figure 31). While most intestine transplants performed
since 1990 have included a liver (51%), this trend has been
decreasing, with combined liver-intestine transplants rep-
resenting 61%, 58% and 43% of intestine transplants over
the three periods examined. Intestinal transplants con-
tinue to be more commonly performed in pediatric patients
(64% in 2001–2005, down from 69% in 1991–1995). In
the most recent era (2001–2005), pediatric intestine trans-
plants combined with a liver were the most common in-
testine transplant performed overall (38%): 60% of all pe-
diatric intestine transplants were combined liver-intestine
transplants. Adult intestine-only transplants are the sec-
ond most common intestine transplant performed overall
(31%): 86% of all adult intestine transplants were intestine-
only (Figure 32).
Intestine graft and patient survival
Following transplantation, there were outcome differences
between patients who received only an intestine and those
Source: SRTR Analysis, May 2006.
Figure 34: Adjusted graft survival following intestine trans-
plantation, 1991–2005.
who received both an intestine and a liver. When adjusted
for age, race and diagnosis, post-transplant graft and pa-
tient survival data were superior for intestine-only recip-
ients; these differences were most apparent at 1 year
following transplantation but diminished at subsequent
time intervals (Figures 33 and 34). The early survival dis-
parity likely reflects the fact that the intestine-liver re-
cipients were much sicker at the time of transplant, as
demonstrated by their higher waiting list mortality, and the
fact that they undergo more extensive surgery than the
intestine-only recipients. The subsequent narrowing of the
gap in graft and patient survival between the two groups
may reflect reduced graft loss due to chronic rejection in
the intestine-liver recipient population, although conclusive
evidence for the immunoprotective effect of the liver on
the intestine graft has been difficult to demonstrate.
Conclusion
Transplantation continues to be a very successful treat-
ment for end-stage liver disease. The number of liver
transplants has increased steadily over the last decade,
with 6441 procedures performed in 2005. This growth
may reflect a larger number of deceased donors, espe-
cially in the ‘expanded donor criteria’ and DCD categories.
Although the long-term outcomes for these recipients re-
main unclear, short-term benefits have been clearly identi-
fied. Patient and graft survival for recipients of DCD grafts
have continued to improve, with 1-year survival rates for
recipients of DCD grafts in 2004 virtually identical to those
seen for recipients of standard criteria grafts. Warm is-
chemia time has been identified as a negative prognostic
indicator, and procurement of livers more than 30 min after
withdrawal of life support now occurs less than 10% of the
time.
The MELD/PELD allocation system continues to be re-
fined. The ‘Share 15’ policy, which mandates sharing of
available organs within a region so that patients with MELD
scores ≥15 receive priority, was implemented in January
of 2005. Subsequently, the number of DSAs transplanting
90% of their recipients at MELD scores ≥15 increased sub-
stantially from 27 (55%) to 42 (86%). However, there was
no significant increase in sharing between DSAs, suggest-
ing that available organs were being used for candidates
with higher MELD scores within the DSA of origin.
LDLT has emerged as a viable alternative to deceased
donor transplantation in the past decade, yet there is a
great deal of regional variation in how much it is employed.
A trend toward use in regions with low availability of de-
ceased donors and high average MELD score at trans-
plant may in part explain the regional variability. In the past
decade, LDLT has changed from predominantly parent-to-
child to adult-to-adult LDLT. Patient and graft survival rates
for recipients of LDLT are now equivalent to and in some
cases slightly better than those seen for recipients of stan-
dard criteria grafts.
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Activity in all areas of intestine transplantation continues
to increase. Data now available for recipients of intestine-
alone transplants suggest that patient and graft survival
of this group is superior to that seen for recipients of liver-
intestine grafts in the first posttransplant year. An immuno-
protective effect of the liver may be noted in combined
recipients in subsequent years.
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Note on sources: The articles in this report are based on the reference
table in the 2006 OPTN/SRTR Annual Report, which are not included in this
publication. Many relevant data appear in the figures and tables included
here; other table from the Annual Report that serve as the basis for this
article include the following: Tables 1.6, 9, 1a–b, 9.2a, 9.3, 9.4a–b, 9.7a,
9.10a–b, 9.12a–b, 9.14a–b, and 10.3. All of these tables may be found online
at: http://www.ustransplant.org.
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